My watch list
my.bionity.com  
Login  

12 Current news of Life Technologies

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Thermo Fisher Scientific to Acquire Life Technologies Corporation

16-Apr-2013

Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of ...

more

BAC BV collaborates with Life Technologies to provide new HPLC affinity columns

22-Jun-2011

BAC BV has announced a strategic collaboration with Life Technologies to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. The collaboration will create a range of ready-to-use HPLC columns ...

more

DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak

06-Jun-2011

Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid ...

more

CEVEC Signs Global License Agreement for Human CAP-T Technology with Life Technologies

19-Aug-2010

CEVEC Pharmaceuticals announced the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation. Under the terms of the agreement, Life Technologies and CEVEC will co-operate to offer optimized expression kits based on CEVEC’s proprietary CAP-T cells to the global ...

more

GENEART AG and Applied Biosystems Deutschland GmbH intend to conclude a domination agreement

11-Jun-2010

GENEART AG and its majority shareholder, Applied Biosystems Deutschland GmbH, intend to conclude a domination agreement pursuant to Section 291 et seq. German Stock Corporation Act (Aktiengesetz) with GENEART AG as the dominated entity and Applied Biosystems Deutschland GmbH as the dominating ...

more

Management Board and Supervisory Board of GENEART Recommends Acceptance of Voluntary Public Offer

19-Apr-2010

The Management Board and the Supervisory Board of GENEART AG have announced their joint statement with respect to the voluntary public offer by Applied Biosystems Deutschland GmbH to the shareholders of GENEART AG. This joint statement is in reference to the offer document published by the ...

more

GENEART AG will become part of the US-Based Biotechnology Company Life Technologies Corp.

Life Technologies acquires 58 % of GENEART shares via it´s German subsidiary Applied Biosystems Deutschland GmbH

09-Apr-2010

The founders of GENEART AG Prof. Dr. Ralf Wagner, Prof. Dr. Hans Wolf, Dr. Marcus Graf, and individual members of the management as well as the venture capital companies EquiNet EarlyStage Capital and S-REFIT AG, have signed contracts with Applied Biosystems Deutschland GmbH for selling their ...

more

Invitrogen Announces Opening of Hepatocyte Supply Facility in Warrington, UK

08-Dec-2009

Invitrogen, part of Life Technologies Corporation, announced the opening of a new facility in Warrington, UK, which will supply freshly isolated human hepatocytes to researchers in Europe. Human hepatocytes isolated from liver tissue are used for many biopharmaceutical applications, by ...

more

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

07-Sep-2009

Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ...

more

SciGene Signs Reagent Supply Agreement with Life Technologies

23-Mar-2009

SciGene announced that it has entered into an agreement whereby Invitrogen, a division of Life Technologies, will supply SciGene reagents used in its BioPrime® Total Genomic Labeling System. SciGene will incorporate the reagents into a kit for use on the ArrayPrep™ Target Preparation System, a ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE